Skip to main content
. 2020 Oct 23;22(12):669–700. doi: 10.1021/acscombsci.0c00099

Figure 3.

Figure 3

Co-delivery of curcumin and siRNA in cancer therapy with focus on molecular signaling pathways. Down-regulation of Bcl-2, elF5A2, and STAT3 by siRNA increases the antitumor activity of curcumin against cancer cells. Nanoparticles promote cellular accumulation of siRNA and curcumin to enhance their antitumor potential.